Browse studies

Find your next paid study

7 recruiting studies matching your filters

Omission of Immediate Postoperative Radiation in Patients With Intermediate Pathological Risk Features and Negative Two-Week Post-Operative ctHPVDNA (OPERATION Trial)

This single-arm Phase II trial evaluates whether omission of postoperative radiotherapy is feasible and oncologically safe in select patients with HPV-associat…

Squamous Cell CarcinomaHuman Papilloma Virus (HPV)Oropharyngeal Squamous Cell Carcinoma (OPSCC)

Estimated

~$10 – $6,250

Medical University of South CarolinaNCT07513389

Phase 3

COVE-3: A Phase 3, Double-blind, Randomized, Vehicle-controlled Study to Evaluate the Efficacy and Safety of YCANTH (VP-102/TO-208) in Subjects With Common Warts (Verruca Vulgaris)

This is a Phase 3, double-blind, randomized, vehicle-controlled study (Study number VP-CW-302; referred to as COVE-3 \[Cantharidin and Occlusion in Verruca Epi…

Common WartsCommon Warts (Verruca Vulgaris)Human Papilloma Virus (HPV)+1 more

Estimated

~$10 – $8,750

Verrica Pharmaceuticals Inc.NCT07637734

Phase 2

A Phase 2a, Multi-Center, Placebo-Controlled, Double-Blinded, Randomized, Dose Ranging Study of the Preliminary Efficacy of DARE-HPV to Treat Persistent High-Risk Human Papillomavirus (HPV) Genital Infection

The goal of this clinical study is to learn if DARE-HPV can treat persistent high-risk human papillomavirus (hrHPV). The primary outcome will be if the genital…

Human Papilloma Virus (HPV)High-risk Human Papillomavirus Infection

Estimated

~$10 – $8,750

Daré Bioscience, Inc.NCT07601074

Observational

Unidos Contra el VPH: Screening Preference and Uptake of HPV Self-sampling Among Latinxs Along the US-Mexico Border

The purpose of the Unidos Contra el VPH study is to help find options to screen, or check, for cervical cancer that individuals can do at home to help prevent …

Human Papilloma Virus (HPV)Cervical Cancers

Estimated

~$10 – $6,250

University of Texas at AustinNCT06825689

Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

The goal of this study is to test two commercially available technologies for their ability to detect treatment response in patients with cervical cancer follo…

Cervical CancerHuman Papilloma Virus (HPV)

Estimated

~$10 – $750

University of FloridaNCT07214584

Phase 3

COVE-2: A Phase 3, Double-blind, Randomized, Vehicle-controlled Study to Evaluate the Efficacy and Safety of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris)

This is a Phase 3, double-blind, randomized, vehicle-controlled study (Study number VP-CW-301; referred to as COVE-2 \[Cantharidin and Occlusion in Verruca Epi…

Common WartsCommon Warts (Verruca Vulgaris)Human Papilloma Virus (HPV)+1 more

Estimated

~$10 – $8,750

Verrica Pharmaceuticals Inc.NCT07246590

Phase 3

COVE-4: A Phase 3, Open-Label, Long-Term Follow-Up Study to Evaluate the Safety and Efficacy of YCANTH (VP-102/TO-208) in Subjects With Common Warts (Verruca Vulgaris)

People who participated in either the COVE-2 or COVE-3 study for common warts, may be eligible to enroll into this Long Term Follow Up (LTFU) study COVE-4. The…

Common Warts (Verruca Vulgaris)Common WartsHuman Papilloma Virus (HPV)+1 more

Estimated

~$10 – $8,750

Verrica Pharmaceuticals Inc.NCT07457918